Atlas Trials

Safety and Efficacy of the Bispecific T-Cell Engager (BiTE) in Kidney Transplant Recipients With Chronic Active Antibody-Mediated Rejection

Clinical trial NCT07689578 · RECRUITING

Trial details

NCT number
NCT07689578
Sponsor
Turun Song
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Antibody Mediated Rejection After Kidney Transplantation
Start date
2026-07-30
Primary completion
2029-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.